These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1037 related items for PubMed ID: 19035970

  • 1. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM, Vandeplassche L, Kerstens R, Ausma J.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):315-28. PubMed ID: 19035970
    [Abstract] [Full Text] [Related]

  • 2. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L.
    Gut; 2009 Mar 01; 58(3):357-65. PubMed ID: 18987031
    [Abstract] [Full Text] [Related]

  • 3. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M, Kerstens R, Rykx A, Vandeplassche L.
    N Engl J Med; 2008 May 29; 358(22):2344-54. PubMed ID: 18509121
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of linaclotide for patients with chronic constipation.
    Lembo AJ, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Johnston JM.
    Gastroenterology; 2010 Mar 29; 138(3):886-95.e1. PubMed ID: 20045700
    [Abstract] [Full Text] [Related]

  • 5. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.
    Dubois D, Gilet H, Viala-Danten M, Tack J.
    Neurogastroenterol Motil; 2010 Feb 29; 22(2):e54-63. PubMed ID: 19761492
    [Abstract] [Full Text] [Related]

  • 6. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R, Chera D, Gruss HJ, Halphen M.
    Aliment Pharmacol Ther; 2013 May 29; 37(9):876-86. PubMed ID: 23480216
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies.
    Quigley EM, Wald A, Fidelholtz J, Boivin M, Pecher E, Earnest D.
    Clin Gastroenterol Hepatol; 2006 May 29; 4(5):605-13. PubMed ID: 16678076
    [Abstract] [Full Text] [Related]

  • 9. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.
    Mueller-Lissner S, Kamm MA, Wald A, Hinkel U, Koehler U, Richter E, Bubeck J.
    Am J Gastroenterol; 2010 Apr 29; 105(4):897-903. PubMed ID: 20179697
    [Abstract] [Full Text] [Related]

  • 10. Prucalopride is no more effective than placebo for children with functional constipation.
    Mugie SM, Korczowski B, Bodi P, Green A, Kerstens R, Ausma J, Ruth M, Levine A, Benninga MA.
    Gastroenterology; 2014 Dec 29; 147(6):1285-95.e1. PubMed ID: 25239590
    [Abstract] [Full Text] [Related]

  • 11. An investigation of dose titration with darifenacin, an M3-selective receptor antagonist.
    Steers W, Corcos J, Foote J, Kralidis G.
    BJU Int; 2005 Mar 29; 95(4):580-6. PubMed ID: 15705084
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation.
    Müller-Lissner S, Rykx A, Kerstens R, Vandeplassche L.
    Neurogastroenterol Motil; 2010 Sep 29; 22(9):991-8, e255. PubMed ID: 20529205
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 29; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 14. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
    Kamm MA, Müller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B.
    Am J Gastroenterol; 2005 Feb 29; 100(2):362-72. PubMed ID: 15667494
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
    Sloots CE, Rykx A, Cools M, Kerstens R, De Pauw M.
    Dig Dis Sci; 2010 Oct 29; 55(10):2912-21. PubMed ID: 20428949
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
    Yiannakou Y, Piessevaux H, Bouchoucha M, Schiefke I, Filip R, Gabalec L, Dina I, Stephenson D, Kerstens R, Etherson K, Levine A.
    Am J Gastroenterol; 2015 May 29; 110(5):741-8. PubMed ID: 25869393
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
    Piessevaux H, Corazziari E, Rey E, Simren M, Wiechowska-Kozlowska A, Kerstens R, Cools M, Barrett K, Levine A.
    Neurogastroenterol Motil; 2015 Jun 29; 27(6):805-15. PubMed ID: 25808103
    [Abstract] [Full Text] [Related]

  • 19. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
    Dipalma JA, Cleveland MV, McGowan J, Herrera JL.
    Am J Gastroenterol; 2007 Jul 29; 102(7):1436-41. PubMed ID: 17403074
    [Abstract] [Full Text] [Related]

  • 20. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.
    Verne GN, Davis RH, Robinson ME, Gordon JM, Eaker EY, Sninksy CA.
    Am J Gastroenterol; 2003 May 29; 98(5):1112-6. PubMed ID: 12809836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.